219
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

An Exploratory Study of Sleep-Wake Differences of Autonomic Activity in Patients with Mild Cognitive Impairment: The Role of Melatonin as a Modulating Factor

, , , , , , ORCID Icon & show all
Pages 771-781 | Received 05 Nov 2022, Accepted 08 May 2023, Published online: 12 May 2023

References

  • Petersen RC, Caracciolo B, Brayne C, Gauthier S, Jelic V, Fratiglioni L. Mild cognitive impairment: a concept in evolution. J Intern Med. 2014;275(3):214–228. doi:10.1111/joim.12190
  • Ward A, Tardiff S, Dye C, Arrighi HM. Rate of conversion from prodromal Alzheimer’s disease to Alzheimer’s dementia: a systematic review of the literature. Dement Geriatr Cogn Dis Extra. 2013;3(1):320–332. doi:10.1159/000354370
  • Stephan BC, Hunter S, Harris D, et al. The neuropathological profile of mild cognitive impairment (MCI): a systematic review. Mol Psychiatry. 2012;17(11):1056–1076. doi:10.1038/mp.2011.147
  • Jack CR, Bennett DA, Blennow K, et al. NIA-AA research framework: toward a biological definition of Alzheimer’s disease. Alzheimers Dement. 2018;14(4):535–562. doi:10.1016/j.jalz.2018.02.018
  • Buijs FN, Leon-Mercado L, Guzman-Ruiz M, Guerrero-Vargas NN, Romo-Nava F, Buijs RM. The circadian system: a regulatory feedback network of periphery and brain. Physiology. 2016;31(3):170–181. doi:10.1152/physiol.00037.2015
  • Tworoger SS, Lee S, Schernhammer ES, Grodstein F. The association of self-reported sleep duration, difficulty sleeping, and snoring with cognitive function in older women. Alzheimer Dis Assoc Disord. 2006;20(1):41–48. doi:10.1097/01.wad.0000201850.52707.80
  • Lim AS, Yu L, Costa MD, et al. Increased fragmentation of rest-activity patterns is associated with a characteristic pattern of cognitive impairment in older individuals. Sleep. 2012;35(5):633–40B. doi:10.5665/sleep.1820
  • Ju YE, McLeland JS, Toedebusch CD, et al. Sleep quality and preclinical Alzheimer disease. JAMA Neurol. 2013;70(5):587–593. doi:10.1001/jamaneurol.2013.2334
  • Faubel R, Lopez-Garcia E, Guallar-Castillon P, Graciani A, Banegas JR, Rodriguez-Artalejo F. Usual sleep duration and cognitive function in older adults in Spain. J Sleep Res. 2009;18(4):427–435. doi:10.1111/j.1365-2869.2009.00759.x
  • Linden M, Bar T, Helmchen H. Prevalence and appropriateness of psychotropic drug use in old age: results from the Berlin Aging Study (BASE). Int Psychogeriatr. 2004;16(4):461–480. doi:10.1017/s1041610204000420
  • Billioti de Gage S, Moride Y, Ducruet T, et al. Benzodiazepine use and risk of Alzheimer’s disease: case-control study. BMJ. 2014;349:g5205. doi:10.1136/bmj.g5205
  • Kaufmann CN, Spira AP, Alexander GC, Rutkow L, Mojtabai R. Trends in prescribing of sedative-hypnotic medications in the USA: 1993–2010. Pharmacoepidemiol Drug Saf. 2016;25(6):637–645. doi:10.1002/pds.3951
  • Voyer P, Verreault R, Mengue PN, Morin CM. Prevalence of insomnia and its associated factors in elderly long-term care residents. Arch Gerontol Geriatr. 2006;42(1):1–20. doi:10.1016/j.archger.2005.06.008
  • Ancoli-Israel S. Sleep and aging: prevalence of disturbed sleep and treatment considerations in older adults. J Clin Psychiatry. 2005;66(Suppl 9):24–30; quiz 42–3.
  • Toledo MA, Junqueira LF. Cardiac autonomic modulation and cognitive status in Alzheimer’s disease. Clin Auton Res. 2010;20(1):11–17. doi:10.1007/s10286-009-0035-0
  • Collins O, Dillon S, Finucane C, Lawlor B, Kenny RA. Parasympathetic autonomic dysfunction is common in mild cognitive impairment. Neurobiol Aging. 2012;33(10):2324–2333. doi:10.1016/j.neurobiolaging.2011.11.017
  • Malik M. Heart rate variability: standards of measurement, physiological interpretation, and clinical use: task force of the European Society of Cardiology and the North American Society for Pacing and Electrophysiology. Ann Noninvasive Electrocardiol. 1996;1(2):151–181.
  • Stauss HM. Heart rate variability. Am J Physiol Regul Integr Comp Physiol. 2003;285(5):R927–31. doi:10.1152/ajpregu.00452.2003
  • Forte G, Favieri F, Casagrande M. Heart rate variability and cognitive function: a systematic review. Front Neurosci. 2019;13:710. doi:10.3389/fnins.2019.00710
  • Cheng YC, Huang YC, Huang WL. Heart rate variability in patients with dementia or neurocognitive disorders: a systematic review and meta-analysis. Aust N Z J Psychiatry. 2020;4867420976853. doi:10.1177/0004867420976853
  • Liu KY, Elliott T, Knowles M, Howard R. Heart rate variability in relation to cognition and behavior in neurodegenerative diseases: a systematic review and meta-analysis. Ageing Res Rev. 2022;73:101539. doi:10.1016/j.arr.2021.101539
  • Kim MS, Yoon JH, Hong JM. Early differentiation of dementia with Lewy bodies and Alzheimer’s disease: heart rate variability at mild cognitive impairment stage. Clin Neurophysiol. 2018;129(8):1570–1578. doi:10.1016/j.clinph.2018.05.004
  • Nicolini P, Ciulla MM, Malfatto G, et al. Autonomic dysfunction in mild cognitive impairment: evidence from power spectral analysis of heart rate variability in a cross-sectional case-control study. PLoS One. 2014;9(5):e96656. doi:10.1371/journal.pone.0096656
  • Terroba-Chambi C, Abulafia C, Vigo DE, Merello M. Heart rate variability and mild cognitive impairment in Parkinson’s disease. Mov Disord. 2020;35(12):2354–2355. doi:10.1002/mds.28234
  • Kong SDX, Hoyos CM, Phillips CL, et al. Altered heart rate variability during sleep in mild cognitive impairment. Sleep. 2020. doi:10.1093/sleep/zsaa232
  • Grassler B, Dordevic M, Herold F, et al. Relationship between resting state heart rate variability and sleep quality in older adults with mild cognitive impairment. Int J Environ Res Public Health. 2021;18(24):13321. doi:10.3390/ijerph182413321
  • Zulli R, Nicosia F, Borroni B, et al. QT dispersion and heart rate variability abnormalities in Alzheimer’s disease and in mild cognitive impairment. J Am Geriatr Soc. 2005;53(12):2135–2139. doi:10.1111/j.1532-5415.2005.00508.x
  • Kim J-S, Park H-E, Oh Y-S, et al. Blood pressure and heart rate variability in Alzheimer’s disease. Dement Neurocogn Disord. 2015;14(3):128–134.
  • Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256(3):183–194. doi:10.1111/j.1365-2796.2004.01388.x
  • Rey A. Rey auditory verbal learning test (RAVLT). In: L’Examen Clinique En Psychologie. PUF; 1964:5–6.
  • Spreen O, Benton A. Neurosensory Center Comprehensive Examination for Aphasia. Victoria (BC): University of Victoria; 1977.
  • Reitan RM, Wolfson D. The Halstead–Reitan neuropsychological test battery for adults—theoretical, methodological, and validational bases. Neuropsychol Assess Neuropsychiatr Neuromed Disord. 2009;1:3–24.
  • Escobar-Córdoba F, Eslava-Schmalbach J. Validación colombiana del índice de calidad de sueño de Pittsburgh. Revista de Neurologia. 2005;40(3):150–155.
  • Diez JJ, Vigo DE, Lloret SP, et al. Sleep habits, alertness, cortisol levels, and cardiac autonomic activity in short-distance bus drivers: differences between morning and afternoon shifts. J Occup Environ Med. 2011;53(7):806–811. doi:10.1097/JOM.0b013e318221c6de
  • Seely AJ, Macklem PT. Complex systems and the technology of variability analysis. Crit Care. 2004;8(6):R367–84. doi:10.1186/cc2948
  • Vigo DE, Tuerlinckx F, Ogrinz B, et al. Circadian rhythm of autonomic cardiovascular control during Mars500 simulated mission to Mars. Aviat Space Environ Med. 2013;84(10):1023–1028. doi:10.3357/asem.3612.2013
  • Pichot V, Gaspoz JM, Molliex S, et al. Wavelet transform to quantify heart rate variability and to assess its instantaneous changes. J Appl Physiol. 1999;86(3):1081–1091. doi:10.1152/jappl.1999.86.3.1081
  • Jaeger RG, Halliday TR. On confirmatory versus exploratory research. Herpetologica. 1998;1998:S64–S66.
  • McDonald JJB. Handbook of Biological Statistics. 3rd ed. Sparky House Publishing; 2014:3. Available from http://www.biostathandbook.com/transformation.html.
  • Reiner A, Yekutieli D, Benjamini Y. Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics. 2003;19(3):368–375. doi:10.1093/bioinformatics/btf877
  • Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Statist Soc. 1995;57(1):289–300.
  • Glickman ME, Rao SR, Schultz MR. False discovery rate control is a recommended alternative to Bonferroni-type adjustments in health studies. Journal of Clinical Epidemiology. 2014;67(8):850–857. doi:10.1016/j.jclinepi.2014.03.012
  • Terroba-Chambi C, Bruno V, Vigo DE, Merello M. Heart rate variability and falls in Huntington’s disease. Clin Autonomic Res. 2021;31(2):281–292. doi:10.1007/s10286-020-00669-2
  • Feng W, Yokoyama JS, Yu S, et al. APOE genotype affects cognitive training response in healthy shanghai community-dwelling elderly individuals. J Alzheimers Dis. 2015;47(4):1035–1046. doi:10.3233/JAD-150039
  • Rhein C, Muhle C, Richter-Schmidinger T, Alexopoulos P, Doerfler A, Kornhuber J. Neuroanatomical correlates of intelligence in healthy young adults: the role of basal ganglia volume. PLoS One. 2014;9(4):e93623. doi:10.1371/journal.pone.0093623
  • Pereira T, Lemos L, Cardoso S, et al. Predicting progression of mild cognitive impairment to dementia using neuropsychological data: a supervised learning approach using time windows. BMC Med Inform Decis Mak. 2017;17(1):110. doi:10.1186/s12911-017-0497-2
  • Wams EJ, Wilcock GK, Foster RG, Wulff K. Sleep-wake patterns and cognition of older adults with amnestic mild cognitive impairment (aMCI): a comparison with cognitively healthy adults and moderate Alzheimer’s disease patients. Curr Alzheimer Res. 2017;14(10):1030–1041. doi:10.2174/1567205014666170523095634
  • Reda F, Gorgoni M, Lauri G, et al. In search of sleep biomarkers of Alzheimer’s disease: k-complexes do not discriminate between patients with mild cognitive impairment and healthy controls. Brain Sci. 2017;7(12):51. doi:10.3390/brainsci7050051
  • Nelson PT, Trojanowski JQ, Abner EL, et al. “New Old Pathologies”: AD, PART, and cerebral age-related TDP-43 with sclerosis (CARTS). J Neuropathol Exp Neurol. 2016;75(6):482–498. doi:10.1093/jnen/nlw033
  • Westerberg CE, Mander BA, Florczak SM, et al. Concurrent impairments in sleep and memory in amnestic mild cognitive impairment. J Int Neuropsychol Soc. 2012;18(3):490–500. doi:10.1017/S135561771200001X
  • Jeong J. EEG dynamics in patients with Alzheimer’s disease. Clin Neurophysiol. 2004;115(7):1490–1505. doi:10.1016/j.clinph.2004.01.001
  • D’Rozario AL, Chapman JL, Phillips CL, et al. Objective measurement of sleep in mild cognitive impairment: a systematic review and meta-analysis. Sleep Med Rev. 2020;52:101308. doi:10.1016/j.smrv.2020.101308
  • Naismith SL, Rogers NL, Hickie IB, Mackenzie J, Norrie LM, Lewis SJ. Sleep well, think well: sleep-wake disturbance in mild cognitive impairment. J Geriatr Psychiatry Neurol. 2010;23(2):123–130. doi:10.1177/0891988710363710
  • Cavuoto MG, Kinsella GJ, Ong B, Pike KE, Nicholas CL. Naturalistic measurement of sleep in older adults with amnestic mild cognitive impairment: anxiety symptoms do not explain sleep disturbance. Curr Alzheimer Res. 2019;16(3):233–242. doi:10.2174/1567205016666190301104645
  • Holth J, Patel T, Holtzman DM. Sleep in Alzheimer’s disease - beyond amyloid. Neurobiol Sleep Circadian Rhythms. 2017;2:4–14. doi:10.1016/j.nbscr.2016.08.002
  • Tobaldini E, Nobili L, Strada S, Casali KR, Braghiroli A, Montano N. Heart rate variability in normal and pathological sleep. Front Physiol. 2013;4:294. doi:10.3389/fphys.2013.00294
  • Fink AM, Bronas UG, Calik MW. Autonomic regulation during sleep and wakefulness: a review with implications for defining the pathophysiology of neurological disorders. Clin Auton Res. 2018;28(6):509–518. doi:10.1007/s10286-018-0560-9
  • Nishiyama K, Yasue H, Moriyama Y, et al. Acute effects of melatonin administration on cardiovascular autonomic regulation in healthy men. Am Heart J. 2001;141(5):E9. doi:10.1067/mhj.2001.114368
  • Rechcinski T, Trzos E, Wierzbowska-Drabik K, Krzeminska-Pakula M, Kurpesa M. Melatonin for nondippers with coronary artery disease: assessment of blood pressure profile and heart rate variability. Hypertens Res. 2010;33(1):56–61. doi:10.1038/hr.2009.174
  • Campos LA, Bueno C, Barcelos IP, et al. Melatonin therapy improves cardiac autonomic modulation in pinealectomized patients. Front Endocrinol (Lausanne). 2020;11:239. doi:10.3389/fendo.2020.00239
  • Jacquemont T, De Vico Fallani F, Bertrand A, et al. Amyloidosis and neurodegeneration result in distinct structural connectivity patterns in mild cognitive impairment. Neurobiol Aging. 2017;55:177–189. doi:10.1016/j.neurobiolaging.2017.03.023
  • Cardinali DP, Vigo DE, Olivar N, Vidal MF, Furio AM, Brusco LI. Therapeutic application of melatonin in mild cognitive impairment. Am J Neurodegener Dis. 2012;1(3):280–291.
  • Vecchierini MF, Kilic-Huck U, Quera-Salva MA; Members of the MELcgotS. Melatonin (MEL) and its use in neurological diseases and insomnia: recommendations of the French Medical and Research Sleep Society (SFRMS). Rev Neurol (Paris). 2021;177(3):245–259. doi:10.1016/j.neurol.2020.06.009